comprehensive -WSS

comprehensive

author：comprehensive 2025-08-28 13:05:54 - browse：7491

3D dollar signs come out of a prescription drug bottle — coverage from STAT — Adobe

WASHINGTON — Venture capitalists are still pouring money into drug research in spite of Medicare’s new power to negotiate drug prices, according to Congress’ nonpartisan budget experts.

The Inflation Reduction Act includes two measures that directly lower drug prices. Medicare price negotiation is the most controversial of the two. The law gives drugs 9 years on the market before negotiated prices take effect; biologics get 13 years. Drugs are selected for negotiation among the 50 top-selling drugs without generic or biosimilar competition. Medicare will negotiate prices for 10 drugs to start. Up to 60 drugs will be subject to negotiation over the next four years, and up to 20 more drugs every year afterward.

The law also requires drug companies to pay back Medicare when they raise prices on drugs faster than inflation.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： Chris Christie meets with Zelenskyy during Ukraine trip

explore

WSS

When is a doctor not a doctor? Try when patients address women doctors

Chris Christie meets with Zelenskyy during Ukraine trip

7 people shot in DC, police say

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Listen: Biotech layoffs, eye drug drama, & gene therapy milestones

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

hotspot

comprehensive

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Doctor appointment wait times are getting worse

Tori Bowie and the unacceptable rates of Black maternal death

Doctor appointment wait times are getting worse

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Pfizer's Covid pill remains 89% effective in final analysis, company says

As demand for Covid shots wanes, Moderna seeks its next success

Meta looks to target Twitter with a rival app called Threads

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Late stage cancers on the rise after pandemic delayed screenings

entertainment

Physicians aren't 'burning out.' They're suffering from moral injury

Inside the fall of star MIT scientist David Sabatini

Group behind ProMed defends move to subscription

The a glaring gap in research on serious mental illness and primary care

Physicians aren't 'burning out.' They're suffering from moral injury

4th of July breaks record for highest global temperature ever measured

focus

Wikipedia

explore

focus